143 related articles for article (PubMed ID: 9119751)
1. Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells.
Kikuchi Y; Hirata J; Yamamoto K; Ishii K; Kita T; Kudoh K; Tode T; Nagata I; Taniguchi K; Kuwano M
Jpn J Cancer Res; 1997 Feb; 88(2):213-7. PubMed ID: 9119751
[TBL] [Abstract][Full Text] [Related]
2. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
3. Enhanced topoisomerase I activity and increased topoisomerase II alpha content in cisplatin-resistant cancer cell lines.
Minagawa Y; Kigawa J; Irie T; Kanamori Y; Itamochi H; Cheng X; Terakawa N
Jpn J Cancer Res; 1997 Dec; 88(12):1218-23. PubMed ID: 9473741
[TBL] [Abstract][Full Text] [Related]
4. The role of topoisomerase I inhibitor in cisplatin-resistant ovarian cancer.
Minagawa Y; Kigawa J; Itamochi H; Terakawa N
Hum Cell; 2001 Sep; 14(3):237-43. PubMed ID: 11774743
[TBL] [Abstract][Full Text] [Related]
5. Cellular efflux pump and interaction between cisplatin and paclitaxel in ovarian cancer cells.
Kamazawa S; Kigawa J; Minagawa Y; Itamochi H; Shimada M; Takahashi M; Sato S; Akeshima R; Terakawa N
Oncology; 2000 Nov; 59(4):329-35. PubMed ID: 11096346
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y
Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987
[TBL] [Abstract][Full Text] [Related]
7. Possible mechanisms of resistance to cis-diamminedichloroplatinum (II) of human ovarian cancer cells.
Kikuchi Y; Iwano I; Miyauchi M; Kita T; Sugita M; Tenjin Y; Nagata I
Jpn J Cancer Res; 1990; 81(6-7):701-6. PubMed ID: 2119370
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.
Goto S; Yoshida K; Morikawa T; Urata Y; Suzuki K; Kondo T
Cancer Res; 1995 Oct; 55(19):4297-301. PubMed ID: 7671239
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins.
Taniguchi K; Kohno K; Kawanami K; Wada M; Kanematsu T; Kuwano M
Cancer Res; 1996 May; 56(10):2348-54. PubMed ID: 8625310
[TBL] [Abstract][Full Text] [Related]
10. Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.
Sark MW; Timmer-Bosscha H; Meijer C; Uges DR; Sluiter WJ; Peters WH; Mulder NH; de Vries EG
Br J Cancer; 1995 Apr; 71(4):684-90. PubMed ID: 7710929
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
Cheng G; Li Y; Tian F
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
[TBL] [Abstract][Full Text] [Related]
12. Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer.
Naniwa J; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Shimogai R; Kawaguchi W; Sato S; Terakawa N
Int J Gynecol Cancer; 2007; 17(1):76-82. PubMed ID: 17291235
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N
Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616
[TBL] [Abstract][Full Text] [Related]
14. Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cells.
Kikuchi Y; Iwano I; Miyauchi M; Sasa H; Nagata I; Kuki E
Gynecol Oncol; 1990 Nov; 39(2):199-203. PubMed ID: 2227596
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell line.
Kohara H; Tabata M; Kiura K; Ueoka H; Kawata K; Chikamori M; Aoe K; Chikamori K; Matsushita A; Harada M
Clin Cancer Res; 2002 Jan; 8(1):287-92. PubMed ID: 11801571
[TBL] [Abstract][Full Text] [Related]
16. [Isolation of cisplatin-resistant subline from human ovarian cancer cell line and analysis of its cell-biological characteristics].
Yoshiya N; Adachi S; Misawa Y; Yuzawa H; Honda T; Kanazawa K; Takeuchi S Tanaka K; Tanaka K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):7-14. PubMed ID: 2647872
[TBL] [Abstract][Full Text] [Related]
17. Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell line.
de Jong S; Timmer-Bosscha H; de Vries EG; Mulder NH
Int J Cancer; 1993 Jan; 53(1):110-7. PubMed ID: 8380054
[TBL] [Abstract][Full Text] [Related]
18. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK
Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
[TBL] [Abstract][Full Text] [Related]
19. Markedly decreased expression of glutathione S-transferase pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis.
Yokomizo A; Kohno K; Wada M; Ono M; Morrow CS; Cowan KH; Kuwano M
J Biol Chem; 1995 Aug; 270(33):19451-7. PubMed ID: 7642628
[TBL] [Abstract][Full Text] [Related]
20. cis-Diamminedichloroplatinum-resistant cell lines derived from human epithelial ovarian carcinoma express increased susceptibility to angiogenesis inhibitor TNP-470.
Tamura M; Takakuwa K; Tanaka K
Gynecol Oncol; 2004 Feb; 92(2):530-6. PubMed ID: 14766244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]